OWCP - OWC Pharmaceutical Research Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue--50-
Cost of Revenue----
Gross Profit--50-
Operating Expenses
Research Development712441141.858271.394
Selling General and Administrative2,8594,1132,006.2161,380.029
Non Recurring----
Total Operating Expenses3,5714,5542,148.0741,651.423
Operating Income or Loss-3,571-4,554-2,098.074-1,651.423
Income from Continuing Operations
Total Other Income/Expenses Net-6,687-5-189.255-3.565
Earnings Before Interest and Taxes-3,571-4,554-2,098.074-1,651.423
Interest Expense-826-5-5-3.565
Income Before Tax-10,258-4,559-2,287.329-1,654.988
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-10,258-4,559-2,287.329-1,654.988
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-10,258-4,559-2,287.329-1,654.988
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-12,705-4,559-2,287.329-1,654.988